acetylcarnitine has been researched along with Diabetes Mellitus, Type 1 in 6 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
Diabetes Mellitus, Type 1: A subtype of DIABETES MELLITUS that is characterized by INSULIN deficiency. It is manifested by the sudden onset of severe HYPERGLYCEMIA, rapid progression to DIABETIC KETOACIDOSIS, and DEATH unless treated with insulin. The disease may occur at any age, but is most common in childhood or adolescence.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Seven male individuals with type 1 diabetes performed 120 min of aerobic exercise at 55-60% of Vo(2max) randomly on two occasions (glucose clamped to 5 or 11 mmol/l, identical insulinemia)." | 6.76 | Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using ¹H magnetic resonance spectroscopy: a randomized single-blind crossover study. ( Boesch, C; Boss, A; Christ, E; Ith, M; Jenni, S; Kreis, R; Nuoffer, JM; Stettler, C, 2011) |
| "Seven male individuals with type 1 diabetes performed 120 min of aerobic exercise at 55-60% of Vo(2max) randomly on two occasions (glucose clamped to 5 or 11 mmol/l, identical insulinemia)." | 2.76 | Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using ¹H magnetic resonance spectroscopy: a randomized single-blind crossover study. ( Boesch, C; Boss, A; Christ, E; Ith, M; Jenni, S; Kreis, R; Nuoffer, JM; Stettler, C, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rolim, LC | 1 |
| da Silva, EM | 1 |
| Flumignan, RL | 1 |
| Abreu, MM | 1 |
| Dib, SA | 1 |
| Fernandez, IC | 1 |
| Del Carmen Camberos, M | 1 |
| Passicot, GA | 1 |
| Martucci, LC | 1 |
| Cresto, JC | 1 |
| Li, S | 1 |
| Chen, X | 1 |
| Li, Q | 2 |
| Du, J | 1 |
| Liu, Z | 1 |
| Peng, Y | 1 |
| Xu, M | 1 |
| Lei, M | 1 |
| Wang, C | 1 |
| Zheng, S | 1 |
| Zhang, X | 1 |
| Yu, H | 1 |
| Shi, J | 1 |
| Tao, S | 1 |
| Feng, P | 1 |
| Tian, H | 1 |
| Boss, A | 1 |
| Kreis, R | 1 |
| Jenni, S | 1 |
| Ith, M | 1 |
| Nuoffer, JM | 1 |
| Christ, E | 1 |
| Boesch, C | 1 |
| Stettler, C | 1 |
| Hao, Y | 1 |
| Basile, AS | 1 |
| Chen, G | 1 |
| Zhang, L | 1 |
| Quatraro, A | 1 |
| Roca, P | 1 |
| Donzella, C | 1 |
| Acampora, R | 1 |
| Marfella, R | 1 |
| Giugliano, D | 1 |
1 review available for acetylcarnitine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Acetyl-L-carnitine for the treatment of diabetic peripheral neuropathy.
Topics: Acetylcarnitine; Adult; Aged; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropa | 2019 |
3 trials available for acetylcarnitine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Effects of acetyl-L-carnitine and methylcobalamin for diabetic peripheral neuropathy: A multicenter, randomized, double-blind, controlled trial.
Topics: Acetylcarnitine; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Neuropathies; Double | 2016 |
Noninvasive assessment of exercise-related intramyocellular acetylcarnitine in euglycemia and hyperglycemia in patients with type 1 diabetes using ¹H magnetic resonance spectroscopy: a randomized single-blind crossover study.
Topics: Acetylcarnitine; Cross-Over Studies; Diabetes Mellitus, Type 1; Exercise; Humans; Hyperglycemia; Mag | 2011 |
Acetyl-L-carnitine for symptomatic diabetic neuropathy.
Topics: Acetylcarnitine; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Neuropathies; Female; Human | 1995 |
2 other studies available for acetylcarnitine and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Children at risk of diabetes type 1. Treatment with acetyl-L-carnitine plus nicotinamide - case reports.
Topics: Acetylcarnitine; Autoantibodies; Child; Child Development; Child, Preschool; Diabetes Mellitus, Type | 2013 |
Glutamate-induced over-expression of GAD is down-regulated by acetyl-L-carnitine in rat islet cells.
Topics: Acetylcarnitine; Animals; Diabetes Mellitus, Type 1; Down-Regulation; Gene Expression Regulation, En | 2004 |